We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIMX
2851
Himax Technologies
HIMX
$2.56B
$562K ﹤0.01%
75,157
-18,981
-20% -$175K
MHD icon
2852
BlackRock MuniHoldings Fund
MHD
$604M
$562K ﹤0.01%
44,267
+2,137
+5% +$27.9K
XSW icon
2853
State Street SPDR S&P Software & Services ETF
XSW
$515M
$561K ﹤0.01%
5,057
-61
-1% -$7.63K
FCEF icon
2854
First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF
FCEF
$82.6M
$560K ﹤0.01%
28,372
+853
+3% +$18.2K
DWAW icon
2855
AdvisorShares Dorsey Wright FSM All Cap World ETF
DWAW
$94.7M
$559K ﹤0.01%
18,484
-3,349
-15% -$108K
NRP icon
2856
Natural Resource Partners
NRP
$1.36B
$559K ﹤0.01%
+15,019
New +$681K
LCUT icon
2857
Lifetime Brands
LCUT
$219M
$558K ﹤0.01%
50,537
HFXI icon
2858
NYLI FTSE International Equity Currency Neutral ETF
HFXI
$2.12B
$557K ﹤0.01%
26,690
+890
+3% +$19.9K
PDM
2859
Piedmont Realty Trust
PDM
$1.19B
$557K ﹤0.01%
42,435
+971
+2% +$14.6K
HCKT icon
2860
Hackett Group
HCKT
$278M
$556K ﹤0.01%
29,306
+7,676
+35% +$165K
TSN icon
2861
CALL
Tyson Foods
TSN
$19.8B
$554K ﹤0.01%
38,200
-17,100
-31% -$1.53M
MVT
2862
DELISTED
BlackRock MuniVest Fund II
MVT
$552K ﹤0.01%
48,580
+204
+0.4% +$2.45K
CGXU icon
2863
Capital Group International Focus Equity ETF
CGXU
$6.63B
$550K ﹤0.01%
+26,622
New +$596K
EIS icon
2864
iShares MSCI Israel ETF
EIS
$909M
$547K ﹤0.01%
9,238
-1,608
-15% -$106K
OUT icon
2865
Outfront Media
OUT
$5.29B
$547K ﹤0.01%
32,775
-77
-0.2% -$1.68K
TRTX
2866
TPG RE Finance Trust
TRTX
$610M
$547K ﹤0.01%
60,732
-11,223
-16% -$118K
RNST icon
2867
Renasant Corp
RNST
$4B
$543K ﹤0.01%
18,842
-480
-2% -$14.7K
NUSC icon
2868
Nuveen ESG Small-Cap ETF
NUSC
$1.35B
$542K ﹤0.01%
16,530
+2,518
+18% +$90.6K
WNC icon
2869
Wabash National
WNC
$507M
$542K ﹤0.01%
39,922
+574
+1% +$8.28K
USAC icon
2870
USA Compression Partners
USAC
$3.84B
$541K ﹤0.01%
32,369
-6,896
-18% -$124K
COHU icon
2871
Cohu
COHU
$2.76B
$540K ﹤0.01%
19,468
-384
-2% -$10.6K
ECF
2872
Ellsworth Growth & Income Fund
ECF
$178M
$538K ﹤0.01%
63,198
+5,406
+9% +$50.5K
IVOG icon
2873
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.73B
$538K ﹤0.01%
6,810
-44
-0.6% -$3.84K
BANX
2874
ArrowMark Financial
BANX
$200M
$537K ﹤0.01%
27,966
+2,353
+9% +$46.5K
ADMA icon
2875
ADMA Biologics
ADMA
$2.19B
$532K ﹤0.01%
268,656
+68,672
+34% +$135K

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.